Cas:1318338-47-4 N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine manufacturer & supplier

Chemical Name:N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

CAS.NO:1318338-47-4

Synonyms:4-Dibenzofuranamine, N-[1,1′-biphenyl]-4-yl-;N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine;N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine

Molecular Formula:C₂₄H₁₇NO

Molecular Weight:335.398

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:542.0±33.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.728

PSA:

Exact Mass:335.131012

LogP:6.93

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Dibenzofuranamine, N-[1,1′-biphenyl]-4-yl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine Use and application,N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine technical grade,usp/ep/jp grade.

Related News: Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine manufacturer Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine supplier TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine vendor It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. N-([1,1′-biphenyl]-4-yl)dibenzo[b,d]furan-4-amine factory Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.